Halozyme Therapeutics shares owned by Bernzott Capital Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Bernzott Capital Advisors
from 13F filings
Historical chart of Bernzott Capital Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Bernzott Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Bernzott Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.1M | 69k | 73.34 |
| 2025-06-30 | $3.7M | 70k | 52.02 |
| 2025-03-31 | $6.5M | 102k | 63.81 |
| 2024-12-31 | $4.5M | 94k | 47.81 |
| 2024-06-30 | $9.8M | 187k | 52.36 |
| 2024-03-31 | $8.5M | 210k | 40.68 |
| 2023-12-31 | $4.6M | 125k | 36.96 |
| 2023-09-30 | $6.6M | 172k | 38.20 |
| 2023-06-30 | $11M | 304k | 36.07 |
| 2023-03-31 | $12M | 321k | 38.19 |
| 2022-12-31 | $25M | 445k | 56.90 |
| 2022-09-30 | $18M | 456k | 39.54 |
| 2022-06-30 | $16M | 373k | 44.00 |
| 2022-03-31 | $10M | 256k | 39.88 |